As of January 2025, Helix Biopharma has a market cap of $130.01M. This makes Helix Biopharma the world's 17922th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $22.78M | -19.05% |
2023 | $28.15M | -4.55% |
2022 | $29.49M | -26.67% |
2021 | $40.21M | -40.00% |
2020 | $67.01M | -62.69% |
2019 | $179.60M | 152.83% |
2018 | $71.04M | -43.62% |
2017 | $125.99M | -38.96% |
2016 | $206.40M | -23.00% |
2015 | $268.06M | 11.11% |
2014 | $241.25M | 25.00% |
2013 | $193.00M | 22.03% |
2012 | $158.15M | -37.89% |
2011 | $254.65M | -26.07% |
2010 | $344.45M | -19.94% |
2009 | $430.23M | 68.95% |
2008 | $254.65M | -13.64% |
2007 | $294.86M | 18.92% |
2006 | $247.95M | -55.10% |
2005 | $552.20M | 17.71% |
2004 | $469.10M | -20.45% |
2003 | $589.72M | 47.16% |
2002 | $400.74M | 22.54% |
2001 | $327.03M | -61.88% |
2000 | $857.78M | 218.41% |
1999 | $269.40M | 402.50% |
1998 | $53.61M | 0.00% |
1997 | $53.61M | -75.76% |
1996 | $221.15M | - |